Business Wire – Forest Laboratories, Inc. and Gedeon Richter Plc Announce Results from a Phase II Study of Cariprazine for the Treatment of Bipolar Depression

Disclaimer of Medical Advice:

The information supplied on this website is for informational purposes only and is not meant to replace advise from your doctor or other health care professional or any information contained in or on any packaging or product. You should not use the information on this website for treatment or diagnosis of any health problem or condition or for prescription of any medication or other treatment. You should consult with a qualified healthcare professional prior to beginning any exercise, diet or supplementation program of any kind, before taking any medication, or if you either have or suspect you may have a health problem or condition. You should not stop taking any medication prescribed to you by your physician or other health care professional without first consulting your doctor.